Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Rho-inhibition and neuroprotective effect on rotenone-treated dopaminergic neurons in vitro.

Mattii L, Pardini C, Ippolito C, Bianchi F, Sabbatini ARM, Vaglini F.

Neurotoxicology. 2019 May;72:51-60. doi: 10.1016/j.neuro.2019.02.006. Epub 2019 Feb 12.

PMID:
30769001
2.

Connexin 26 Expression in Mammalian Cardiomyocytes.

Moscato S, Cabiati M, Bianchi F, Vaglini F, Morales MA, Burchielli S, Botta L, Sabbatini ARM, Falleni A, Del Ry S, Mattii L.

Sci Rep. 2018 Sep 18;8(1):13975. doi: 10.1038/s41598-018-32405-2.

3.

Melanocortin Receptor-4 and Glioblastoma Cells: Effects of the Selective Antagonist ML00253764 Alone and in Combination with Temozolomide In Vitro and In Vivo.

Vaglini F, Pardini C, Di Desidero T, Orlandi P, Pasqualetti F, Ottani A, Pacini S, Giuliani D, Guarini S, Bocci G.

Mol Neurobiol. 2018 Jun;55(6):4984-4997. doi: 10.1007/s12035-017-0702-4. Epub 2017 Aug 8.

PMID:
28791594
4.

Recovery from experimental parkinsonism by intrastriatal application of erythropoietin or EPO-releasing neural precursors.

Carelli S, Giallongo T, Viaggi C, Latorre E, Gombalova Z, Raspa A, Mazza M, Vaglini F, Di Giulio AM, Gorio A.

Neuropharmacology. 2017 Jun;119:76-90. doi: 10.1016/j.neuropharm.2017.03.035. Epub 2017 Apr 1.

PMID:
28373075
5.

Fluorescent light induces neurodegeneration in the rodent nigrostriatal system but near infrared LED light does not.

Romeo S, Vitale F, Viaggi C, di Marco S, Aloisi G, Fasciani I, Pardini C, Pietrantoni I, Di Paolo M, Riccitelli S, Maccarone R, Mattei C, Capannolo M, Rossi M, Capozzo A, Corsini GU, Scarnati E, Lozzi L, Vaglini F, Maggio R.

Brain Res. 2017 May 1;1662:87-101. doi: 10.1016/j.brainres.2017.02.026. Epub 2017 Mar 2.

PMID:
28263713
6.

Grafted Neural Precursors Integrate Into Mouse Striatum, Differentiate and Promote Recovery of Function Through Release of Erythropoietin in MPTP-Treated Mice.

Carelli S, Giallongo T, Viaggi C, Gombalova Z, Latorre E, Mazza M, Vaglini F, Di Giulio AM, Gorio A.

ASN Neuro. 2016 Oct 27;8(5). pii: 1759091416676147. Print 2016 Oct.

7.

Clarifying CLARITY: Quantitative Optimization of the Diffusion Based Delipidation Protocol for Genetically Labeled Tissue.

Magliaro C, Callara AL, Mattei G, Morcinelli M, Viaggi C, Vaglini F, Ahluwalia A.

Front Neurosci. 2016 Apr 25;10:179. doi: 10.3389/fnins.2016.00179. eCollection 2016.

8.

Effect of itraconazole on mouse mesencephalic neurons.

Giorgi C, Fausto C, Pardini C, Simili M, Del Carratore R, Vaglini F.

Int J Dev Neurosci. 2015 Aug;44:75-83. doi: 10.1016/j.ijdevneu.2015.06.002. Epub 2015 Jun 9.

PMID:
26065977
9.

Serotonin abnormalities in Engrailed-2 knockout mice: New insight relevant for a model of Autism Spectrum Disorder.

Viaggi C, Gerace C, Pardini C, Corsini GU, Vaglini F.

Neurochem Int. 2015 Aug;87:34-42. doi: 10.1016/j.neuint.2015.05.004. Epub 2015 May 19.

PMID:
26002543
10.

Acetaldehyde and parkinsonism: role of CYP450 2E1.

Vaglini F, Viaggi C, Piro V, Pardini C, Gerace C, Scarselli M, Corsini GU.

Front Behav Neurosci. 2013 Jun 21;7:71. doi: 10.3389/fnbeh.2013.00071. eCollection 2013.

11.

Bright light exposure reduces TH-positive dopamine neurons: implications of light pollution in Parkinson's disease epidemiology.

Romeo S, Viaggi C, Di Camillo D, Willis AW, Lozzi L, Rocchi C, Capannolo M, Aloisi G, Vaglini F, Maccarone R, Caleo M, Missale C, Racette BA, Corsini GU, Maggio R.

Sci Rep. 2013;3:1395. doi: 10.1038/srep01395.

12.

A novel method to produce immobilised biomolecular concentration gradients to study cell activities: design and modelling.

Vozzi G, Lenzi T, Montemurro F, Pardini C, Vaglini F, Ahluwalia A.

Mol Biotechnol. 2012 Feb;50(2):99-107. doi: 10.1007/s12033-011-9411-9.

PMID:
21544696
13.

Behavioral, neurochemical, and electrophysiological changes in an early spontaneous mouse model of nigrostriatal degeneration.

Sgadò P, Viaggi C, Pinna A, Marrone C, Vaglini F, Pontis S, Mercuri NB, Morelli M, Corsini GU.

Neurotox Res. 2011 Aug;20(2):170-81. doi: 10.1007/s12640-010-9232-9. Epub 2010 Nov 23.

PMID:
21104462
14.

Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone.

Nesti C, Pardini C, Barachini S, D'Alessandro D, Siciliano G, Murri L, Petrini M, Vaglini F.

Brain Res. 2011 Jan 7;1367:94-102. doi: 10.1016/j.brainres.2010.09.042. Epub 2010 Sep 18.

PMID:
20854799
15.

Automated extraction and classification of dynamic metrical features of morphological development in dissociated Purkinje neurons.

Billeci L, Pioggia G, Vaglini F, Ahluwalia A.

J Neurosci Methods. 2010 Jan 15;185(2):315-24. doi: 10.1016/j.jneumeth.2009.10.004. Epub 2009 Oct 28.

PMID:
19837112
16.

Assessment and comparison of neural morphology through metrical feature extraction and analysis in neuron and neuron-glia cultures.

Billeci L, Pioggia G, Vaglini F, Ahluwalia A.

J Biol Phys. 2009 Oct;35(4):447-64. doi: 10.1007/s10867-009-9150-3. Epub 2009 Apr 29.

17.

MPTP-induced model of Parkinson's disease in cytochrome P450 2E1 knockout mice.

Viaggi C, Vaglini F, Pardini C, Caramelli A, Corsini GU.

Neuropharmacology. 2009 Jun;56(8):1075-81. doi: 10.1016/j.neuropharm.2009.03.003. Epub 2009 Mar 17.

PMID:
19298832
18.

Increased susceptibility to kainic acid-induced seizures in Engrailed-2 knockout mice.

Tripathi PP, Sgadò P, Scali M, Viaggi C, Casarosa S, Simon HH, Vaglini F, Corsini GU, Bozzi Y.

Neuroscience. 2009 Mar 17;159(2):842-9. doi: 10.1016/j.neuroscience.2009.01.007. Epub 2009 Jan 10.

PMID:
19186208
19.

Ethanol intake and ethanol-induced locomotion and locomotor sensitization in Cyp2e1 knockout mice.

Correa M, Viaggi C, Escrig MA, Pascual M, Guerri C, Vaglini F, Aragon CM, Corsini GU.

Pharmacogenet Genomics. 2009 Mar;19(3):217-25. doi: 10.1097/FPC.0b013e328324e726.

PMID:
19177030
20.

Apomorphine offers new insight into dopaminergic neuron vulnerability in mesencephalic cultures.

Vaglini F, Pardini C, Viaggi C, Caramelli A, Corsini GU.

Neuropharmacology. 2008 Oct;55(5):737-42. doi: 10.1016/j.neuropharm.2008.06.041. Epub 2008 Jun 27.

PMID:
18634808
21.

Role of CYP2E1 in the mouse model of MPTP toxicity.

Pardini C, Vaglini F, Viaggi C, Caramelli A, Corsini GU.

Parkinsonism Relat Disord. 2008;14 Suppl 2:S119-23. doi: 10.1016/j.parkreldis.2008.04.014. Epub 2008 Jun 25. Review.

PMID:
18583171
22.

CYP 2E1 mutant mice are resistant to DDC-induced enhancement of MPTP toxicity.

Viaggi C, Vaglini F, Pardini C, Sgadò P, Caramelli A, Corsini GU.

J Neural Transm Suppl. 2007;(72):159-63.

PMID:
17982890
23.

The role of mitochondria in stem cell biology.

Nesti C, Pasquali L, Vaglini F, Siciliano G, Murri L.

Biosci Rep. 2007 Jun;27(1-3):165-71. Review.

PMID:
17484045
24.

Cytochrome P450 and Parkinson's disease: protective role of neuronal CYP 2E1 from MPTP toxicity.

Viaggi C, Pardini C, Vaglini F, Corsini GU.

J Neural Transm Suppl. 2006;(70):173-6.

PMID:
17017526
25.

Involvement of cytochrome P450 2E1 in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.

Vaglini F, Pardini C, Viaggi C, Bartoli C, Dinucci D, Corsini GU.

J Neurochem. 2004 Oct;91(2):285-98.

26.

In vitro cytotoxic activities of 2-alkyl-4,6-diheteroalkyl-1,3,5-triazines: new molecules in anticancer research.

Menicagli R, Samaritani S, Signore G, Vaglini F, Dalla Via L.

J Med Chem. 2004 Sep 9;47(19):4649-52.

PMID:
15341480
27.

Dose-dependent induction of apoptosis by R-apomorphine in CHO-K1 cell line in culture.

Pardini C, Vaglini F, Galimberti S, Corsini GU.

Neuropharmacology. 2003 Aug;45(2):182-9.

PMID:
12842124
28.

Dopamine agonists and analogues have an antiproliferative effect on CHO-K1 cells.

Maggio R, Armogida M, Scarselli M, Salvadori F, Longoni B, Pardini C, Chiarenza A, Chiacchio S, Vaglini F, Bernardini R, Colzi A, Corsini GU.

Neurotox Res. 2000 Apr;1(4):285-97.

PMID:
12835096
29.

Dextromethorphan prevents the diethyldithiocarbamate enhancement of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice.

Vaglini F, Pardini C, Bonuccelli U, Maggio R, Corsini GU.

Brain Res. 2003 May 30;973(2):298-302.

PMID:
12738074
30.

Quercetin inhibits the sulfation of r(-)-apomorphine in human brain.

Vietri M, Vaglini F, Cantini R, Pacifici GM.

Int J Clin Pharmacol Ther. 2003 Jan;41(1):30-5.

PMID:
12564743
31.

Sulfation of R(-)-apomorphine in the human liver and duodenum, and its inhibition by mefenamic acid, salicylic acid and quercetin.

Vietri M, Vaglini F, Pietrabissa A, Spisni R, Mosca F, Pacifici GM.

Xenobiotica. 2002 Jul;32(7):587-94.

PMID:
12162854
32.

Cytochrome p450 and parkinsonism: protective role of CYP2E1.

Vaglini F, Pardini C, Viaggi C, Corsini GU.

Funct Neurol. 2001;16(4 Suppl):107-12. Review. No abstract available.

PMID:
11996504
33.

Is lithium able to reverse neurological damage induced by vinca alkaloids? (Short communication).

Petrini M, Vaglini F, Cervetti G, Cavalletti M, Sartucci F, Murri L, Corsini GU.

J Neural Transm (Vienna). 1999;106(5-6):569-75.

PMID:
10443559
34.

Apomorphine has a potent antiproliferative effect on Chinese hamster ovary cells.

Scarselli M, Barbier P, Salvadori F, Armogida M, Collecchi P, Pardini C, Vaglini F, Maggio R, Corsini GU.

J Neural Transm Suppl. 1999;55:47-55.

PMID:
10335492
35.

Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors.

Maggio R, Riva M, Vaglini F, Fornai F, Molteni R, Armogida M, Racagni G, Corsini GU.

J Neurochem. 1998 Dec;71(6):2439-46.

36.

Species differences in the role of excitatory amino acids in experimental parkinsonism.

Fornai F, Vaglini F, Maggio R, Bonuccelli U, Corsini GU.

Neurosci Biobehav Rev. 1997 Jul;21(4):401-15. Review.

PMID:
9195598
37.

Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism.

Maggio R, Riva M, Vaglini F, Fornai F, Racagni G, Corsini GU.

J Neural Transm (Vienna). 1997;104(10):1113-23.

PMID:
9503263
38.

L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.

Vaglini F, Pardini C, Cavalletti M, Maggio R, Corsini GU.

Brain Res. 1996 Nov 25;741(1-2):68-74.

PMID:
9001706
39.

Striatal MPP+ levels do not necessarily correlate with striatal dopamine levels after MPTP treatment in mice.

Vaglini F, Fascetti F, Tedeschi D, Cavalletti M, Fornai F, Corsini GU.

Neurodegeneration. 1996 Jun;5(2):129-36.

PMID:
8819133
40.

Excitatory amino acids and MPTP toxicity.

Fornai F, Vaglini F, Maggio R, Bonuccelli U, Corsini GU.

Adv Neurol. 1996;69:167-76. Review. No abstract available.

PMID:
8615126
41.
42.

Stereoselective inhibition of muscarinic receptor subtypes by the eight stereoisomers related to rociverine.

Barbier P, Renzetti AR, Turbanti L, Di Bugno C, Fornai F, Vaglini F, Maggio R, Corsini GU.

Eur J Pharmacol. 1995 Jul 18;290(2):125-32.

PMID:
8575526
43.

Role of excitatory amino-acids in diethyldithiocarbamate-induced cell death in mesencephalic cultures.

Vaglini F, Pardini C, Maggio R, Corsini GU.

Brain Res. 1995 Mar 13;674(1):127-32.

PMID:
7773680
44.

(+)MK-801 prevents the DDC-induced enhancement of MPTP toxicity in mice.

Vaglini F, Fascetti F, Fornai F, Maggio R, Corsini GU.

Brain Res. 1994 Dec 30;668(1-2):194-203.

PMID:
7704605
45.

beta,beta'-Iminodipropionitrile-induced persistent dyskinetic syndrome in mice is transiently modified by MPTP.

Fornai F, Alessandri MG, Saginario A, Vaglini F, Corsini GU.

Brain Res. 1993 Mar 5;605(1):93-100.

PMID:
7682144
46.

MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates.

Zuddas A, Oberto G, Vaglini F, Fascetti F, Fornai F, Corsini GU.

J Neurochem. 1992 Aug;59(2):733-9.

PMID:
1629743
47.

Pharmacologic modulation of MPTP toxicity: MK 801 in prevention of dopaminergic cell death in monkeys and mice.

Zuddas A, Vaglini F, Fornai F, Fascetti F, Saginario A, Corsini GU.

Ann N Y Acad Sci. 1992 May 11;648:268-71. No abstract available.

PMID:
1386204
48.

Selective lesion of the nigrostriatal dopaminergic pathway by MPTP and acetaldehyde or diethyldithiocarbamate.

Zuddas A, Vaglini F, Fornai F, Corsini GU.

Neurochem Int. 1992 Mar;20 Suppl:287S-293S.

PMID:
1365444
49.

Pharmacological modulation of development and plasticity in nigro striatal dopaminergic neurons.

Zuddas A, Vaglini F, Fornai F, Corsini GU.

Pharmacol Res. 1992 Feb-Mar;25 Suppl 1:29-30. No abstract available.

PMID:
1354859
50.

P-glycoprotein and drug resistance in acute leukemias and in the blastic crisis of chronic myeloid leukemia.

Carulli G, Petrini M, Marini A, Vaglini F, Caracciolo F, Grassi B.

Haematologica. 1990 Nov-Dec;75(6):516-21.

PMID:
1982999

Supplemental Content

Loading ...
Support Center